Course Goals and Objectives
Child and Adolescent
Psychopharmacology
Whether or not to medicate mental health disorders during
pregnancy is a complex decision involving maternal health as well as
possible adverse effects on the unborn child.  Similarly, medicating
youth is equally important and controversial.  On the one hand
should medicines be administered to youths with psychological
disorders, offering positive benefits but perhaps altering the
developing brain?  Do short-term benefits translate into long-term
improvements, or might harm follow?

Incorporating the latest literature, Dr. Julien will address the fetal
effects of maternal drug intake and, in children, the treatment of
behavioral aggression, anger, autism, ADHD, depression
(emphasizing medication efficacy and medication-related suicide),
anxiety disorders and bipolar disorder.  This seminar is intended for
all those who work with women of child-bearing age as well as those
who work with children and adolescents with mental health disorders.

GOALS:

.
Most importantly, you will learn to incorporate this
material into your clinical practice.
  • Present the controversies in medicating very young (preschool)
    children.

  • Provide optimum pharmacology for medicating pregnant females.

  • Review medications used in the treatment of ADHD, aggressive
    disorders, anxiety disorders, autism and bipolar disorder in
    children and adolescents.

  • Resolve the controversy and present the pharmacology of
    antidepressant drug use in children and adolescents.

  • Provide optimum pharmacology for medicating children and
    adolescents with behavioral and mental health problems.